JN
Jenil Navin Kothari
About Jenil Navin Kothari
Data last updated:
Jenil Navin Kothari is a Director at Medicure Global Pharma Private Limited (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medicure Global Pharma Private Limited U47721MH2025PTC462454 | Director | 10 Dec 2025 | 2025 | Active |
Board colleagues of Jenil Navin Kothari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ayush Naresh Chopra | 10542582 | Medicure Global Pharma Private Limited | Director |
| Chaitya Anil Surana | 09628443 | Medicure Global Pharma Private Limited | Director |
| Kshitij Yogesh Bafna | 11400493 | Medicure Global Pharma Private Limited | Director |
| Mangilal Bhikamchand Jain | 10542614 | Medicure Global Pharma Private Limited | Director |
| Rashika Ronak Jain | 10542596 | Medicure Global Pharma Private Limited | Director |
| Ronak Mangilal Jain | 10542379 | Medicure Global Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jenil Navin Kothari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jenil Navin Kothari
Jenil Navin Kothari currently holds 1 directorship: Medicure Global Pharma Private Limited (Director, since 10 Dec 2025).
Jenil Navin Kothari was first appointed on 10 Dec 2025 as Director at Medicure Global Pharma Private Limited.
The current boards of Jenil Navin Kothari's companies include Ayush Naresh Chopra (Medicure Global Pharma Private Limited), Chaitya Anil Surana (Medicure Global Pharma Private Limited), Kshitij Yogesh Bafna (Medicure Global Pharma Private Limited), Mangilal Bhikamchand Jain (Medicure Global Pharma Private Limited), Rashika Ronak Jain (Medicure Global Pharma Private Limited), Ronak Mangilal Jain (Medicure Global Pharma Private Limited).